MARKER THERAPEUTICS, INC. Amortization of Debt Issuance Costs
MARKER THERAPEUTICS, INC. (MRKR) reported Amortization of Debt Issuance Costs of $0 for the 3-month period ending 2015-03-31, per its 10-Q/A filed 2016-04-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2016-04-14
- MARKER THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2014-03-31 was $35.27K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 3 month as first filed |
|---|---|---|
| 2015-03-31 | $0.00 10-Q/A · filed 2016-04-14 | |
| 2014-03-31 | $35.27K 10-Q/A · filed 2016-04-14 | -$35.27K 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |